Episode   |  232

The best of Scaling Up 2026 – When measurement starts paying off

Is better measurement translating into real patient growth? Discover how healthcare leaders are using data, AI, and smarter strategies to improve marketing decisions, optimize patient experiences, and drive sustainable growth.

Episode Highlights:

Brooke Newton, VP of Marketing & Growth, AllerVie Health: “The goal wasn’t a prettier dashboard. It was a faster, more confident growth decision. When a leader asks a follow-up in a meeting, the answer is a click rather than a week of reconciling a bunch of spreadsheets, getting back to your leader and saying, ‘I really don’t know today. I’ll find out tomorrow.’”

Episode overview

Healthcare marketers have spent years building better measurement. Now, the real opportunity is turning that data into smarter decisions and patient growth.

In this special episode of the Ignite Healthcare Marketing Podcast, we’re sharing standout conversations from Scaling Up 2026. Hear from healthcare marketing leaders at Cleveland Clinic, Action Behavior Centers, AllerVie Health, and others, alongside experts from Google and Meta, explore how better measurement is driving growth, how AI is changing patient discovery and advertising, and why what happens after the click matters just as much.

In this episode, you’ll learn

  • How better measurement helps marketers forecast growth and justify bigger investments
  • What healthcare boards need to see before approving marketing budgets
  • How AI is changing patient search, advertising, and marketing decisions
  • Why appointment availability and booking experiences can limit patient growth

As healthcare marketing moves into 2027, the opportunity isn’t just better data. It’s knowing what to do with it. Tune in for practical perspectives on turning measurement into smarter growth decisions.

Related Resources

Announcer: Welcome to the Ignite Podcast, the only healthcare marketing podcast that digs into the digital strategies and tactics that help you accelerate growth. Each week, Cardinal’s experts explore innovative ways to build your digital presence and attract more patients. Buckle up for another episode of Ignite.

Ashley Petrochenko: Hey, everybody. Welcome back to the Ignite Healthcare Marketing Podcast. Ashley Petrochenko here, VP of Marketing here at Cardinal. Last month, we hosted Scaling Up, Cardinal’s two-day healthcare performance marketing summit. This is our fourth year bringing together marketers. If you weren’t able to make the event, you’re in luck. We’re going to share some of our takeaways on this podcast episode.

One theme that kept coming up across the summit was that building a measurement foundation takes time. Four years ago, with Scaling Up, much of the conversations were dominated by measurement in a HIPAA-compliant manner, rebuilding your marketing tech stack. Since then, healthcare marketers have come a long way. This year, the organizations that joined Scaling Up have put in the work, and now they’re seeing the payoff.

They’re able to forecast new patient growth, make the case to the board for investments to increase marketing spend, and they’re really able to identify what are the marketing levers that drive new patient growth. That’s really important now because as AI continues to change how patients find care and how marketers even do their job, having that measurement foundation in place is becoming an even more important component. It’s not just about collecting better data anymore. It’s about knowing what to do with that information and how to act. That’s why we are calling 2027 the year of the decision.

Today, we’re going to be sharing some of our favorite conversations from Scaling Up, starting with Action Behavior Centers. Here’s Amy Welsh, ABC’s VP of Marketing Analytics, on what their first-year measurement work looked like, how it has progressed year-over-year, and what that work has made possible.

Amy Welsh: The first year was really focused on fixing attribution and finding gaps. I think one of the things Matt quickly identified when he started was that we had a bunch of leads coming in with the source classified as other. We didn’t know where they were coming from. We knew it was either walk-in or call-in. The reason that those were so important to us is that they moved faster through the funnel. We needed to figure out where they were coming from and how we could get more of those.

We knew one of the first things that we really needed to do was set up call tracking to get visibility into how they were finding our phone number, how they were calling us, and how do we create more of that. I knew the potential unlock that could have for us knowing where those leads came from. We actually got set up with Invoca about a year ago to get that visibility and make sure that we were present where our families were looking for us and then find other ways that they could reach out to us.

Host 1: Amy, how did that visibility help you understand what different neighborhoods needed to build demand? Obviously, we wish it was a one-size-fits-all strategy here, but that is clearly not the case. How has call tracking really enabled you to look at different things to understand how marketing strategy needs to change amongst neighborhoods, not just markets?

Amy: It helped complete the picture for us. I think one of the things that we needed to have is we needed to have that to better understand how many leads were coming from what sources in what pockets of a market. All of our markets are split out into neighborhoods, and we were able to create these campaigns with the Cardinal team of let’s figure out what works in this pocket. This pocket doesn’t need as much paid efforts because they’re getting it organically. We can pull back, but on the other side of the market, they don’t get any organic traction. We now see that. We are not seeing calls from our Google business listing. We are not seeing calls from the website. We are heavily reliant on paid. We need to push more in that pocket.

It completed the picture to allow us to go that granular. Then it gave me the power to then have the conversations with our operations team of what’s going on in this pocket, what centers in this pocket need the most help, and then to then say, not just, “Do you need leads?” but “Are you handling the leads that you’re getting? Again, that transparency of the signals that we’re getting from the conversation analytics, we can look at, yes, these centers need leads; they’re getting them, but they’re not processing them. They’re not getting to the next step.

Ashley: Similar to Action Behavior Centers, other clients of ours have put in the hard work. They have been building the marketing tech stack, implementing call tracking, unifying their data so that they had a single source of truth. This client knew that they had room to grow, but needed to understand how much more could they invest. What that actual investment would deliver. Alex Kemp from our analytics team and Scott Cameron, group media director at Cardinal, walk us through how building that better measurement foundation and building an accurate forecasting model helped them answer those questions and get the client the budget they needed to meet their goals next year. Let’s hear from Alex.

Alex Kemp: A lot of times we see instances where the KPI of a given brand might be leads, and those leads might be all phone calls, all form submissions. While you can forecast off of that data, it’s not as impactful as if you were forecasting a true, more bottom-of-the-funnel signal that indicates someone actually either booking at your office or actually attending an appointment.

The really important foundation that we had to lay before this was getting that really clean signal, and not just a clean signal, but a HIPAA-compliant signal. This involved unifying phone calls, online bookings, and form submissions into one single source of truth that was end-to-end in a compliant way using click IDs. Again, the idea here is that we had one single definition of what a new patient booking was that both Cardinal and the client had agreed on of saying, “This is our KPI. This is how we’re going to hold ourselves accountable. This is what success looks like.”

We could have predicted off of phone calls, and form submissions, and online bookings, but that wouldn’t have given us as an impactful KPI to talk to the client when we’re talking about forecasting and justifying that increase in budget. The thing that matters here, the main takeaway, is without a trustworthy number, there’s nothing to forecast on. Again, garbage in doesn’t just mean garbage out, but it also means an unfalsifiable out. While it may be helpful to say, “If we spend this much, we’re going to get this many leads next month,” but the next natural question is how many bookings or patients I’m going to get from those leads. Having a really solid foundation of this data infrastructure and the clean signal is really useful when we’re talking about forecasting.

Scott Cameron: In our case, we had a client with really ambitious goals, and they chose an increase in spend that was very significant, armed with the knowledge, of course, of what we expected to get in terms of increased new patient bookings. What was the outcome? Budget was approved near the top of the range. We had a really ambitious growth targets, which meant ambitious investment. Budget scaled really quickly, and we could clearly see once we started that budget influx that we were not saturated in our campaigns yet. The campaigns where we were ready to take on more spend and return efficient new patient bookings, everything skyrocketed and took off.

Our cost per new patient stayed below our target. With the increase in spend and only a small increase in the cost per new patient booking, we did see a loss of efficiency as we continued to scale it up as we expected. Again, within that comfortable threshold, we scaled spend and drove 130% increase in new patient bookings versus the same period last year. Because I’m really skeptical of percentage increases without raw numbers, as you probably are too, I include the actual booking numbers here. We had 16,000 more new patient bookings this year. We scaled without spending into diminishing returns. Since we weren’t guessing at that point of diminishing returns anymore, we had the model to show us.

Ashley: Having the right data is one thing. In some ways, I think marketers are drowning in data. How do you get leadership to trust it? How do you get leadership buy-in? That’s another story, and just as equally hard and important. At Scaling Up, Brooke Newton, the VP of Marketing and Growth at AllerVie Health, she shared what it takes to turn that data into a decision and a strategy that leaders can get behind.

Brooke Newton: In January of 2026, we had multiple spreadsheets, separate marketing and PSC reports, manual pulls and reconciliation, hard to answer a follow-up, and everything looked backwards. Today, we have one attribution platform, one growth team scorecard, a source to opportunity to booking, reasons not booked, and a location-level visibility. The goal wasn’t a prettier dashboard. It was a faster, more confident growth decision. When a leader asks a follow-up in a meeting, the answer is a click rather than a week of reconciling and a bunch of spreadsheets, getting back to your leader and saying, “I really don’t know today. I’ll find out tomorrow.”

A board doesn’t want a channel report. They want answers to three questions. Is marketing working? We show them new patient opportunities, bookings, and conversions by location, not impressions, not cost per lead. Where does the next dollar go? Demand and conversions by location. Budget follow is the signal. Can we trust these numbers? That’s the one that decides whether you get funding.

One scorecard, one shared definitions, reconciled before every single board cycle. Three habits that help. Start from the question. Then show the view that answers. Lead with the answer, then the evidence. Then show the limits. Boards trust people who say, “Here’s what we can measure, and here’s what we’re going to get to.”

Ashley: As marketers have built the measurement foundation over the past four years, the patient journey has also fundamentally changed. AI is playing a greater role in how patients find and choose care. Amanda Todorovich from Cleveland Clinic shared what she’s seen in the space today.

Host 2: Amanda, I would love to start with you. Where have you seen discovery change? Where is it changing in ways that you don’t have as much control as you maybe did in the past?

Amanda Todorovich: The last year has been an interesting one to pay attention to what consumers are doing, for sure. I think the way that people traditionally search in Google with keywords and things like that, trying to look at conditions and symptoms and issues and challenges and trying to find care, has changed. People are still doing that, but they’re doing it quite differently, and they’re doing it a little bit less because they’re using the AI models, et cetera.

When they’re using the AI models, they’re asking such specific, personalized, situational questions, and those platforms and tools remember them and know them and know their circumstances and are answering their questions in such a different way than we’re able to do in a traditional search experience. A lot of it has to do with thinking through what kind of advice are they getting? Are they actually getting to the right care in the right ways through those channels and those platforms? What can we do to influence that versus just relying on them to make their way to our information on our site and our experiences?

This shift of wanting to rank for every keyword to the challenge of what prompts are you even trying to show up for when nobody’s asking the same prompt or the same question the same way, it’s becoming incredibly hard, I think, for us to influence things when they’re able to factor in how much gas is in their gas tank, how much money is in their bank account, what insurance do they have. How are they navigating care decisions today is so different. None of those models have any privacy laws, so they’re allowed to feel like your friend and address you personally in this way that feels incredibly trustworthy, even though the information can be completely inaccurate, but the average consumer who’s reading at a fifth-grade level has no idea that it’s wrong.

Ashley: At Scaling Up this year, we welcomed speakers from both Google and Meta to give their perspective on how the landscape is shifting and what AI’s impact is. Here’s Jonathan McGowan at Google. He explains how AI is helping patients move from research to decisions faster and why the provider’s website still matters.

Host 3: Google’s main mission since inception, at least Google Ads, was driving traffic to websites to drive conversions and drive performance. Now, what is the role of the website now with AIO? To the point you made earlier about decision compression is happening and much more vetting and qualification is happening pre-click, how does that change the role of the website once the user finally goes there?

Jonathan McGowan: I would say the website is more foundational than ever before because with AI, whether paid or organic, the algorithm’s been able to understand signals and content in ways that it hadn’t before. A provider’s website not only informs how they show up organically within AIOs, AIO reviews, and AI mode, but also from a paid standpoint. Those signals drive ROI in both experiences. The key point here is that AIO reviews and AI mode are not replacing the provider website. All we’re doing is bringing that user to the front door of that provider’s website faster.

Ashley: Patient journey is happening on other channels more and more. While a website still matters, much of the journey is happening before someone even gets to your site. It’s making it harder and harder to see the full picture. At Scaling Up, marketers shared how they’re approaching that problem, how they’re thinking about measurement. Here’s Valerie Stover from Affordable Care sharing what her team is seeing.

Valerie Stover: What’s going on with organic? [chuckles] That is what I get every day, like every day. It’s easy to see why, right? Our trackable lead events are down. For years, that’s how we proved organic was working. I’m not panicked, which makes everybody else panic more, but I don’t think organic’s broken. The measurement is right. The patient journey got shorter, or it’s happening more behind the curtain.

Someone sees our listing, skims a few reviews or AI summaries, then calls the clinic. They didn’t have to call the clinic to get the information to start with, so our measurable lead events, they’re diminished. Fewer clicks, fewer page views, fewer steps to track. The conversation I keep trying to scare everybody to is, the traffic went down, and I’m okay with that. The actions that we used to count went away, but the patients didn’t go. My conversion rate is up. Our new patients are up.

Ashley: Not only is AI changing how patients find care, it’s also fundamentally changing how marketers work. Across scaling up, every speaker shared that AI is now a routine part of their workflow. We heard two perspectives on what that looks like on the ad platform. Here’s Emily Brill from Meta sharing how the patient journey is evolving and compressing as patients can move from research to decision much faster.

Host 3: Emily, what healthcare trends is Meta seeing that most marketers haven’t caught up to yet, would you say? What’s the blue sky out there that marketers should be thinking about in 2026 and 2027?

Emily Brill: I think in the context of this audience, and what we’ve already been talking about, the trend I’d really focus on is decision speed. We’ve seen that AI has really compressed the time between a patient having a health question and taking action. We’ve just been talking about that at length. We know that in reality, many healthcare organizations are still managing marketing through monthly, quarterly reporting and decision cycles. Well, now, I would say the gap is not often access to data; it’s really the distance between knowing that data and acting on it.

I think in the context of AI, you can really use AI to help summarize performance, identify patterns, surface questions that really deserve attention, and to shorten that cycle between what’s happening and why and applying that learning. As we’re going to talk about, AI has improved so many of our advertising systems and our algorithm to make us more reactive to every signal we’re receiving. I think the question is, how can your own marketing processes and teams also be nimble with all the AI tools at our disposal?

Ashley: Now on the ad platforms themselves, marketers are used to having a lot of control, pulling manual levers to determine who sees an ad. Now that is shifting as AI is taking a greater control in targeting, and your creative plays a much greater role now. Here’s Claire Tang from Meta on what that looks like today and what they’re planning for the future at Meta.

Host 3: How much should teams still work on targeting strategies? How much should we just get five unique concepts creative-wise and throw them into Meta’s algorithm and just have Meta do the work for us in terms of finding the most likely patient?

Claire: That’s a great question. Really, the blunt answer here is that we highly recommend teams stop spending their best thinking on audience targeting and instead think about your portfolio’s assets as your primary targeting layer. The system is strong enough today, with all of the updates we’ve made in the past couple of years, the power of AI to find your patients, but it can’t invent the reason they stopped scrolling. It can’t produce for you today that content that your team can come up with to have that thumb-stopping moment where the user is engaging with your assets, considering it, and taking that next action, whatever that looks like for your business goals and the objectives that you’ve selected for your campaigns.

Targeting hasn’t disappeared. Definitely acknowledge that there are fewer targeting levers to pull in Ads Manager today as you’re building your campaigns. It moved. We’re really steering delivery now through the objectives that we’re selecting at the campaign level. The signal quality that we’re sharing back to the system and through your creative, far beyond interest layering stacks and constrained hyper-targeting today. What agencies and advertisers can really take ownership of is the objectives and the events that you’re choosing to optimize your campaigns toward and the creative that you’re feeding into the system, whether that creative is thumb-stopping and whether it is diverse.

I think that’s the other piece of the puzzle here, particularly for those who might be listening in that are sitting in a really highly regulated space, say pharma, say medical device. We’ve realized there are a lot of constraints on the volume that you can put into the system today, and that’s been a big conversation. Meta is sharing that 10-plus assets per ad set is the best practice, and that is very much the case. Not always a reality for healthcare marketers. Thinking through beyond volume, how diverse are the assets that you’re putting into the system to allow it to go out and find those most efficient converters who are most likely to take that next action?

Ashley: As marketers relinquish more of the controls and advertising to AI, that means that data matters more than ever. As they say, garbage in, garbage out. If you don’t have the right data and the right signals feeding the algorithms, you’re not going to get a high-quality product or leads from that platform. Jonathan McGowan from Google shared what marketers should be prioritizing now to prepare for the AI future.

Jonathan: I work with quite a few advertisers where there is a considerable amount of consolidation efforts happening right now. I think those who have not prioritized consolidation of data, improved data quality, consolidation of signal within campaigns will find that their performance within AI search, and certainly as it scales, I think they’ll find it harder and harder to keep up and keep pace with their competitors. Suffice to say, those who are not prioritizing those efforts to consolidate accordingly will start to realize some of that over the next 12 to 18 months.

I think advertisers certainly who are not yet exploring AI Max and PMax, to Evan’s point, it’s not the solution for everything, for every campaign, for every advertiser, but I think those are core capabilities at this point that are the foundation for the future of search. I would say advertisers and marketers who have not yet prioritized some of these areas to start thinking about how do they improve their data quality, how do they aggregate data volume, and how can they start to test and scale on some of these AI capabilities with the controls that we have available today to be ready for the future and for their businesses as well.

Ashley: Beyond advertising, AI is changing how marketing teams work every day. Amanda Todorovich from Cleveland Clinic shared how her team is using it, as well as some of the creative ways to better understand patients.

Amanda: It’s all day, every day. If I have a meeting with a partner or with anybody that’s not in, I don’t know, like, “Help me prep for this. What should I be prepared for?” I have built my own thought partner agent that is just part of my day. It’s my partner in my job. It’s helped me tremendously be a better leader and make smarter, more educated decisions. Then, obviously, it’s important for my entire team to be using it. It’s also about showcasing that and walking the walk and giving them examples of how I’ve been using it. That’s led to us having about 65 different custom GPTs, agents, or assistance automations throughout our workflows, really just in the digital marketing content space.

I think one of my favorite examples that I think is really differentiating, especially as we’re talking about patient journeys, is really actually to put yourself in the patient’s shoes. We have an empathy agent that is very much about how does it feel to have this condition? What are the things that are going through their mind? What are the things they’re talking about to one another in patient forums and things like that? It’s trained on publicly available information from patients in their own communities. It helps us just be grounded in that always.

Ashley: Better measurement, AI insights, and connected data are giving marketers new ways to understand patients and to make smarter, more informed decisions. New patient acquisition also means looking not just at advertising and driving that booking, but understanding what happens next. What does the patient experience actually look like? Grace Elliott from Orthodontic Partners shared what her team is doing to improve appointment inventory, what patient preferences are, and how to design a booking experience that is going to maximize your provider utilization rates.

Grace Elliott: I want to introduce a new metric that we looked at, which is booking window distribution. That is essentially looking at categories of booking windows and seeing what percentage of patients are being booked within certain date ranges of booking windows. We found over half of our total new patient leads were being scheduled at what, at the time, was our best practice benchmark of over 10 days. Looking back now, how foolish were we? In fact, our average booking window was 19 days. That alone, I could have brought that to the operations team, I know, and said, “Fix that,” but I knew my people. I needed to go further than just that.

We took a look at what does it actually mean if a patient is booked out at different particular booking windows. We looked at patients’ kept rates. How often are they keeping their consultations for different booking windows? What we found, unfortunately, was that it got much worse as we dug in. A delayed booking window can reduce a kept rate by as much as 500 basis points, 5%. I’m sharing again with full transparency because I know for many of us, 5%, either direction, can make or break our ability to reach performance goals. This, plus the booking window distribution, was what I brought to our operators.

Ashley: Grace showed us how long wait times can affect patient bookings, but having more availability isn’t always the answer either. I really like this example from Kayla Shoup at Tend Dental. Her research discovered some surprising insights about how patients perceive appointment availability and why a ton of open appointments might not be the best approach. Here’s what she says.

Kayla Shoup: We used to show every open slot Tuesday at 2:00, 2:30, 18 more that week. We believed that showing every open slot was transparent and convenient, and it made people want to book with us, but to a patient looking at a premium practice, a wide calendar doesn’t say available. It says nobody else picked this place or that this is a walk-in. Nobody complained about it. It just showed up as hesitation. Hesitation in the funnel is one of the hardest things to be able to see. We scaled back, and we started showing fewer options across morning, afternoon, and evening. We had a whole clock. Then the full calendar is just one tap away in case the times that we provided don’t fit your schedule. By doing so, we learned that our calendar is a message and not a data feed. It tells patients something about us, whether we mean it to or not.

We borrowed a pattern from a platform a patient already trusts. That’s really a restaurant app and modeling how do you book a table at a restaurant. They’re not showing you every single table. They’re just showing you a few times. Because there are a few, they feel chosen. When they pick one, we hold it, and we tell them that we’re holding it and same studio, same chairs, the calendar just stopped describing our capacity. Then from there, we created really four rules around that. We show a few really well. Spread them across mornings, afternoons, and evenings so that one fits the patient’s life. Then name the limit so it never feels like a trick. Always keep a way through to the full calendar.

I want to be clear because I think some people might see this and think this is curation, it’s scarcity, but every slot is real and every slot is still bookable. That’s why we made the display decision to show only a few at a time.

Ashley: Those are just a few of the highlights from Scaling Up. If there’s one thing we heard throughout the summit, it’s that building a strong measurement foundation takes time, but the work is paying off. We’re seeing teams make smarter investment decisions, rapidly adapting to how AI is changing healthcare marketing and decisioning. They’re finding new ways to turn patient demand into real growth. That’s what we’ve been talking about when we called 2027 the year of the decision. It’s not just about having better data; it’s about what do we do with it.

A big thank you to everyone who joined us at Scaling Up this year and our presenting sponsors, Liine, Freshpaint, and Patient Prism, for helping make the event possible. If you missed the summit, no worries, you still can listen to the replay. I’m dropping in the show notes a link to sign up to watch the replay. Thanks for listening, and we’ll see you next time on Ignite.

Announcer: Thanks for listening to this episode of Ignite. Interested in keeping up with the latest trends in healthcare marketing? Subscribe to our podcast and leave a rating and review. For more healthcare marketing tips, visit our blog at cardinaldigitalmarketing.com.

Healthcare Marketing Insights At Your Fingertips

Listen and subscribe to Ignite wherever you get your podcasts.